Gut barrier dysfunction in critically ill surgical patients with abdominal compartment syndrome

Pancreas

Volumn 39, Issue 7, 2010, Pages 1064-1069

  Al Bahrani, Ahmed Z ^a,b   Darwish, Ammar ^a,b   Hamza, Numan ^a,b   Benson, Jonathon ^a   Eddleston, Jane M ^a   Snider, Richard H ^c   Nylén, Eric S ^c   Becker, Kenneth L ^c   Barclay, George Robin ^d   Ammori, Basil J ^a,b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

abdominal compartment syndrome; acute pancreatitis; endotoxin; gut barrier; intra abdominal hypertension; sepsis

Indexed keywords

ENDOTOXIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROCALCITONIN;

ABDOMINAL COMPARTMENT SYNDROME; ABDOMINAL PRESSURE; ACUTE PANCREATITIS; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTESTINE FUNCTION; INTESTINE FUNCTION DISORDER; INTRAABDOMINAL HYPERTENSION; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SURGICAL PATIENT;

ABDOMINAL CAVITY; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; COHORT STUDIES; COMPARTMENT SYNDROMES; CRITICAL ILLNESS; FEMALE; HUMANS; HYPERTENSION; INTESTINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 77957352047     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181da8d51     Document Type: Article

References (61)

1. Sugrue M, Buist MD, Hourihan F, et al. Prospective study of intra-abdominal hypertension and renal function after laparotomy. Br J Surg. 1995;82:235-238.
2. Malbrain ML. Abdominal pressure in the critically ill: measurement and clinical relevance. Intensive Care Med. 1999;25:1453-1458.
3. Malbrain ML, Chiumello D, Pelosi P, et al. Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med. 2004;30:822-829.
4. Malbrain ML, Cheatham ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med. 2006;32:1722-1732.
5. Eddy V, Nunn C, Morris JA Jr. Abdominal compartment syndrome. The Nashville experience. Surg Clin North Am. 1997;77:801-812.
6. Sugerman HJ, Bloomfield GL, Saggi BW. Multisystem organ failure secondary to increased intraabdominal pressure. Infection. 1999;27: 61-66.
7. Al-Bahrani AZ, Abid GH, Holt A, et al. Clinical relevance of intra-abdominal hypertension in patients with severe acute pancreatitis. Pancreas. 2008;36:39-43.
8. De Waele JJ, Leppäniemi AK. Intra-abdominal hypertension in acute pancreatitis. World J Surg. 2009;33:1128-1133.
9. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.
10. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;20:411-417.
11. Carrico CJ, Meakins JL, Marshall JC, et al. Multiple-organ-failure syndrome. Arch Surg. 1986;121:196-208.
12. Border JR, Hassett J, LaDuca J, et al. The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg. 1987;206:427-448.
13. Fink MP. Effect of critical illness on microbial translocation and gastrointestinal mucosa permeability. Semin Respir Infect. 1994;9: 256-260.
14. Kanwar S, Windsor AC, Welsh F, et al. Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery. Ann Surg. 2000;231:88-95.
15. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993;128:586-590.
16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
17. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-710.
18. Sugrue M. Abdominal compartment syndrome. Curr Opin Crit Care. 2005;11:333-338.
19. Cheatham ML, Malbrain ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med. 2007;33:951-962.
20. Fusco MA, Martin RS, Chang MC. Estimation of intra-abdominal pressure by bladder pressure measurement: validity and methodology. J Trauma. 2001;50:297-302.
21. Becker KL, Snider RH, Nylen ES. The procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36:941-952.
22. Barclay GR, Scott BB. Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies. Infect Immun. 1987; 55:2706-2714.
23. Windsor JA, Fearon KC, Ross JA, et al. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg. 1993;80: 1042-1046.
24. Mythen MG, Barclay GR, Purdy G, et al. The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction. Blood Coagul Fibrinolysis. 1993;4:999-1005.
25. Oppenheim BA, Barclay GR, Morris J, et al. Antibodies to endotoxin core in sudden infant death syndrome. Arch Dis Child. 1994;70: 95-98.
26. De Waele JJ, Hoste E, Blot SI, et al. Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care. 2005;9:452-457.
27. Malbrain ML. Abdominal pressure in the critically ill. Curr Opin Crit Care. 2000;6:17-29.
28. Cullen DJ, Coyle JP, Teplick R, et al. Cardiovascular, pulmonary, and renal effects of massively increased intra-abdominal pressure in critically ill patients. Crit Care Med. 1989;17:118-121.
29. Schein M, Wittmann DH, Aprahamian CC, et al. The abdominal compartment syndrome: the physiological and clinical consequences of elevated intra-abdominal pressure. J Am Coll Surg. 1995;180: 745-753.
30. Meldrum DR, Moore FA, Moore EE, et al. Prospective characterization and selective management of the abdominal compartment syndrome. Am J Surg. 1997;174:667-672.
31. Biffl WL, Moore EE, Burch JM, et al. Secondary abdominal compartment syndrome is a highly lethal event. Am J Surg. 2001;182: 645-648.
32. Hunter JD, Damani Z. Intra-abdominal hypertension and the abdominal compartment syndrome. Anaesthesia. 2004;59:899-907.
33. Malbrain ML, Chiumello D, Pelosi P, et al. Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med. 2005;33:315-322.
34. Caldwell CB, Ricotta JJ. Changes in visceral blood flow with elevated intraabdominal pressure. J Surg Res. 1987;43:14-20.
35. Eleftheriadis E, Kotzampassi K, Papanotas K, et al. Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats. World J Surg. 1996;20:11-16.
36. Moore-Olufemi SD, Xue H, Allen SJ, et al. Effects of primary and secondary intra-abdominal hypertension on mesenteric lymph flow: implications for the abdominal compartment syndrome. Shock. 2005;23:571-575.
37. Duzgun AP, Gulgez B, Ozmutlu A, et al. The relationship between intestinal hypoperfusion and serum D-lactate levels during experimental intra-abdominal hypertension. Dig Dis Sci. 2006;51:2400-2403.
38. Ivatury RR, Porter JM, Simon RJ, et al. Intra-abdominal hypertension after life-threatening penetrating abdominal trauma: prophylaxis, incidence, and clinical relevance to gastric mucosal pH and abdominal compartment syndrome. J Trauma. 1998;44:1016-1021.
39. Cheatham ML, White MW, Sagraves SG, et al. Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension. J Trauma. 2000;49:621-626.
40. Sugrue M, Jones F, Deane SA, et al. Intra-abdominal hypertension is an independent cause of postoperative renal impairment. Arch Surg. 1999;134:1082-1085.
41. Bailey J, Shapiro MJ. Abdominal compartment syndrome. Crit Care. 2000;4:23-29.
42. Diebel LN, Dulchavsky SA, Wilson RF. Effect of increased intra-abdominal pressure on mesenteric arterial and intestinal mucosal blood flow. J Trauma. 1992;33:45-48.
43. Ammori BJ, Leeder PC, King RF, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg. 1999;3:252-262.
44. Vincent JL, Laterre PF, Cohen J, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock. 2005;23: 400-405.
45. Diebel LN, Dulchavsky SA, Brown WJ. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome. J Trauma. 1997;43:852-855.
46. Yagci G, Zeybek N, Kaymakcioglu N, et al. Increased intra-abdominal pressure causes bacterial translocation in rabbits. J Chin Med Assoc. 2005;68:172-177.
47. Becker KL, Monaghan KG, Silva OL. Immunocytochemical localization of calcitonin in Kulchitsky cells of human lung. Arch Pathol Lab Med. 1980;104:196-198.
48. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-518.
49. Nylen ES, Snider RH Jr, Thompson KA, et al. Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci. 1996;312:12-18.
50. Muller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly. 2001;131:595-602.
51. Rau BM, Frigerio I, Büchler MW, et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg. 2007;142:134-142.
52. Ammori BJ, Becker KL, Kite P, et al. Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission. Br J Surg. 2003;90:197-204.
53. Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg. 2007;245:745-754.
54. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605-1608.
55. Preas HL 2nd, Nylén ES, Snider RH, et al. Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis. 2001;184:373-376.
56. Ammori BJ, Becker KL, Kite P, et al. Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas. 2003;27:239-243.
57. Balogh Z, McKinley BA, Cox CS Jr, et al. Abdominal compartment syndrome: the cause or effect of postinjury multiple organ failure. Shock. 2003;20:483-492.
58. Latenser BA, Kowal-Vern A, Kimball D, et al. A pilot study comparing percutaneous decompression with decompressive laparotomy for acute abdominal compartment syndrome in thermal injury. J Burn Care Rehabil. 2002;23:190-195.
59. Reckard JM, Chung MH, Varma MK, et al. Management of intraabdominal hypertension by percutaneous catheter drainage. J Vasc Interv Radiol. 2005;16:1019-1021.
60. Burch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am. 1996;76:833-842.
61. Joynt GM, Ramsay SJ, Buckley TA. Intra-abdominal hypertension - implications for the intensive care physician. Ann Acad Med Singapore. 2001;30:310-319.